marketingAuthorisationHolder
P26890
predicate
Indicates the entity that holds the official authorization to market or sell a product, typically a medicinal or regulated product, in a given jurisdiction.
All labels observed (6)
| Label | Occurrences |
|---|---|
| marketingAuthorizationHolder | 14 |
| marketingAuthorisationHolder canonical | 2 |
| currentMarketingAuthorizationHolder | 1 |
| hasCurrentMarketingAuthorizationHolder | 1 |
| hasMarketingAuthorisationHolder | 1 |
| hasMarketingAuthorizationHolder | 1 |
Description generation (PDg)
The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.
Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning. # Instructions Focus on describing the relationship, not the entities themselves. # Response Format Begin the description with \' Indicates...\'
Input
Predicate: marketingAuthorisationHolder
Generated description
Indicates the entity that holds the official authorization to market or sell a product, typically a medicinal or regulated product, in a given jurisdiction.
Sample triples (20)
| Subject | Object |
|---|---|
| Fampyra |
Biogen
ⓘ
surface form:
Biogen Netherlands B.V.
|
| rVSV-ZEBOV | Merck & Co. via predicate surface "marketingAuthorizationHolder" ⓘ |
| Waylivra | Ionis Pharmaceuticals ⓘ |
| Truvada |
Gilead Sciences (board member)
via predicate surface "marketingAuthorizationHolder"
ⓘ
surface form:
Gilead Sciences
|
| Ervebo |
Merck & Co.
via predicate surface "hasMarketingAuthorizationHolder"
ⓘ
surface form:
Merck Sharp & Dohme Corp.
|
| Onpattro | Alnylam Pharmaceuticals via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Oxlumo | Alnylam Pharmaceuticals via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Amvuttra | Alnylam Pharmaceuticals via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Singulair | Merck & Co. via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Ebixa | Lundbeck via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Farxiga | AstraZeneca via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Radicava ORS | Mitsubishi Tanabe Pharma America via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Entresto | Novartis via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Kymriah | Novartis Pharma AG via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Aristada | Alkermes plc via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Simponi | Janssen Biotech via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| isatuximab | Sanofi via predicate surface "marketingAuthorizationHolder" NERFINISHED ⓘ |
| Ofatumumab | Novartis via predicate surface "currentMarketingAuthorizationHolder" NERFINISHED ⓘ |
| Zabdeno | Janssen-Cilag International NV via predicate surface "hasMarketingAuthorisationHolder" NERFINISHED ⓘ |
| fenfluramine | UCB Pharma via predicate surface "hasCurrentMarketingAuthorizationHolder" NERFINISHED ⓘ |